Literature DB >> 11001376

Prognostic factors in early rheumatoid arthritis.

D L Scott1.   

Abstract

The current paradigm for rheumatoid arthritis suggests that persistent synovitis leads to erosive joint damage, progression of which results in functional disability. Studies of X-ray progression followed for 1-9 yr have shown that 40-83% of subsequent progression can be predicted by a combination of prognostic factors such as joint involvement, high levels of C-reactive protein and rheumatoid factor (RF) positivity. There are similar findings for predictors of functional disability in studies followed for 2-15 yr. The most consistent prognostic feature is RF positivity, which is equally important in predicting joint damage and functional disability. Immunoglobulin A RF and the co-presence of RF with anti-keratin or anti-filaggrin antibodies may increase levels of prediction. Added value of genetic predictors over that of RF remains inconclusive. Therefore, therapeutic management should be individualized. Cases with active disease and seropositive RF tests merit aggressive therapy; conversely, cases with little synovitis and seronegative tests require conservative management.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11001376     DOI: 10.1093/oxfordjournals.rheumatology.a031490

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  42 in total

Review 1.  Combination therapy in rheumatoid arthritis.

Authors:  S Bingham; P Emery
Journal:  Springer Semin Immunopathol       Date:  2001

2.  The challenge of following process, damage, and function in patients with rheumatoid arthritis in clinical care.

Authors:  Josef S Smolen; Daniel Aletaha
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

3.  Patients with rheumatoid arthritis in clinical care.

Authors:  J S Smolen; D Aletaha
Journal:  Ann Rheum Dis       Date:  2004-03       Impact factor: 19.103

4.  Ex vivo interleukin 1 receptor antagonist production on lipopolysaccharide stimulation is associated with rheumatoid arthritis and with joint damage.

Authors:  J K de Vries-Bouwstra; Y P M Goekoop-Ruiterman; J Wesoly; H J Hulsmans; A J M de Craen; F C Breedveld; B A C Dijkmans; C F Allaart; T W J Huizinga
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

5.  The relation between joint erosion and generalized osteoporosis and disease activity in patients with rheumatoid arthritis.

Authors:  Filiz Sivas; Nurdan Barça; Mustafa Onder; Kürşat Ozoran
Journal:  Rheumatol Int       Date:  2006-04-20       Impact factor: 2.631

6.  Activin A: a potential therapeutic target for characterizing and stopping joint pain early in rheumatoid arthritis patients.

Authors:  Fei Dong; Xijing He
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

7.  Assessing rheumatologists and radiologists agreement rate regarding the diagnosis of focal bone erosions and osteopenic changes using hand X-rays radiography in patients with rheumatoid arthritis.

Authors:  Arman Ahmadzadeh; Pooneh Dehghan; Alireza Rajaee; Mohammadmehdi Emam; Katayoun Enteshari; Latif Gachkar
Journal:  Rheumatol Int       Date:  2013-02-05       Impact factor: 2.631

Review 8.  Modulating co-stimulation: a rational strategy in the treatment of rheumatoid arthritis?

Authors:  Vivianne Malmström; Christina Trollmo; Lars Klareskog
Journal:  Arthritis Res Ther       Date:  2005-03-16       Impact factor: 5.156

9.  Rheumatoid factor is a marker of disease severity in Korean rheumatoid arthritis.

Authors:  Yoo Seob Shin; Jeong Hee Choi; Dong Ho Nahm; Hae Sim Park; Jae Hyun Cho; Chang Hee Suh
Journal:  Yonsei Med J       Date:  2005-08-31       Impact factor: 2.759

Review 10.  Impact of inflammation on the osteoblast in rheumatic diseases.

Authors:  Rebecca Baum; Ellen M Gravallese
Journal:  Curr Osteoporos Rep       Date:  2014-03       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.